Gupta, V. K. (2023). Bimatoprost Ophthalmic Solution (BOS) 0.3 mg w/v for 1 Open Trial of Long-term Preventive Therapy of Migraine in 3 patients with Pathophysiologic Shift from Brain to Eye. Journal of Neuroscience and Neurological Disorders, 7(2), 134–154. https://doi.org/10.29328/journal.jnnd.1001087